Tablets can halve the risk of COVID-19
Scientists in the United States have claimed that an
experimental oral medication to prevent corona has had good results. Clinical
trials say it could halve the risk of hospitalization or death. News BBC.
This tablet named Molnupiravir is the first pill recommended for Corona. This antiviral pill should be taken by the patient twice a day.
U.S. drugmaker Mark says test results are so positive that
outside observers are calling for the trial to be closed soon.
The manufacturer said it would apply to the U.S. authorities
within a week or two for permission for emergency use.
President Joe Biden's chief medical adviser. Anthony Fawcett
called it "very good news." But the U.S. Food and Drug Administration
has called for caution until the FDA reviews the data.
If regulatory authorities allow, Molnupiravir is going to be
the first oral antiviral drug for corona.
This bill was originally made for the treatment of
influenza. It is designed in such a way that the virus enters the genetic code
and becomes aware of the error, preventing the error from spreading to the
body.
Positive results have been obtained using the drug in the
body of 775 patients. However, although the information was published in the
form of a press release, it has not been peer-reviewed yet.
Most covid vaccines are made by targeting spike proteins on
the outside of the virus. There, the pill attacks the enzyme that the virus
uses to replicate itself.
The drug-maker Mark is known in the UK as MSD. They say they
will try to make Molnupiravir work in the same way as the new type of corona
that has been changed in the future.
